| RS1315847764 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 26, Cardiovascular phenotype |
| RS1315862965 |
COL4A3
|
Health Risk |
Pathogenic/Likely pathogenic |
COL4A3-related disorder, Alport syndrome 3b |
| RS1315864029 |
SCN10A
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome, Cardiovascular phenotype |
| RS1315864916 |
NF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 2 |
| RS1315877654 |
COL6A3
|
Health Risk |
Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1315898207 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1315905872 |
SLX4
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1315923578 |
GALNT12
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS1315925055 |
ABCC6
|
Health Risk |
Likely pathogenic |
Autosomal recessive inherited pseudoxanthoma elasticum, Autosomal recessive inherited pseudoxanthoma elasticum |
| RS1315958299 |
CEP41
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1315968443 |
NPHS1
|
Health Risk |
Pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1315983507 |
JAK3
|
Health Risk |
Pathogenic |
T-B+ severe combined immunodeficiency due to JAK3 deficiency, T-B+ severe combined immunodeficiency due to JAK3 deficiency |
| RS1316032472 |
ATP7B
|
Health Risk |
Pathogenic/Likely pathogenic |
Wilson disease, Wilson disease |
| RS1316039692 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS1316078638 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1316082064 |
ADAMTSL4
|
Health Risk |
Pathogenic |
— |
| RS1316112168 |
PREPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Myasthenic syndrome, congenital |
| RS1316114457 |
RAD51D
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS1316130438 |
PFKM
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type VII |
| RS1316134526 |
ALPK3
|
Health Risk |
Pathogenic |
— |
| RS1316166172 |
TAT
|
Health Risk |
Pathogenic/Likely pathogenic |
Tyrosinemia type II, Tyrosinemia type II |
| RS1316176181 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1316178162 |
HEXA
|
Health Risk |
Conflicting classifications of pathogenicity |
Tay-Sachs disease, Tay-Sachs disease |
| RS1316220949 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1316227824 |
AARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1316228094 |
SLC25A26
|
Health Risk |
Likely pathogenic |
Combined oxidative phosphorylation deficiency 28, Combined oxidative phosphorylation deficiency 28 |
| RS1316230541 |
CACNA1H
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic generalized epilepsy, Hyperaldosteronism |
| RS1316240731 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS1316281505 |
FAM161A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Inborn genetic diseases |
| RS1316287327 |
NDUFV1
|
Health Risk |
Likely pathogenic |
Leigh syndrome, Leigh syndrome |
| RS1316294712 |
DNMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary sensory neuropathy-deafness-dementia syndrome, Hereditary sensory neuropathy-deafness-dementia syndrome |
| RS1316299165 |
USH1G
|
Health Risk |
Pathogenic |
Usher syndrome type 1G, Usher syndrome type 1G |
| RS1316310273 |
SETD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Luscan-Lumish syndrome, Luscan-Lumish syndrome |
| RS1316339721 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1316343192 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1316347883 |
CHST3
|
Health Risk |
Pathogenic |
Spondyloepiphyseal dysplasia with congenital joint dislocations, Spondyloepiphyseal dysplasia with congenital joint dislocations |
| RS1316356500 |
SCP2
|
Health Risk |
Pathogenic |
— |
| RS1316363979 |
POLG2
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1316380114 |
DSG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 10, Cardiovascular phenotype |
| RS1316385532 |
ATL1
|
Health Risk |
Pathogenic |
ATL1-related spastic paraplegia, recessive |
| RS1316386738 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1316404038 |
PNPLA6
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 39, Hereditary spastic paraplegia 39 |
| RS1316409501 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Endometrial carcinoma, Hereditary cancer-predisposing syndrome |
| RS1316424431 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS1316434470 |
RECQL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Baller-Gerold syndrome, Inborn genetic diseases |
| RS1316448163 |
SLC35A3
|
Health Risk |
Pathogenic |
Autism spectrum disorder - epilepsy - arthrogryposis syndrome, Autism spectrum disorder - epilepsy - arthrogryposis syndrome |
| RS1316472200 |
BBS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 1 |
| RS1316473569 |
AFG2A
|
Health Risk |
Pathogenic |
Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome, Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome |
| RS1316474105 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS1316486592 |
DHCR7
|
Health Risk |
Pathogenic |
Smith-Lemli-Opitz syndrome, Smith-Lemli-Opitz syndrome |
| RS1316523481 |
TTN
|
Health Risk |
Pathogenic |
— |
| RS1316527998 |
HBA1
|
Health Risk |
Likely pathogenic |
alpha Thalassemia, alpha Thalassemia |
| RS1316575607 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, NEB-related disorder |
| RS1316593215 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1316618431 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1316638883 |
IFNGR2
|
Health Risk |
Likely pathogenic |
Immunodeficiency 28, Immunodeficiency 28 |
| RS1316648174 |
SLX4
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1316655042 |
PXDN
|
Health Risk |
Pathogenic |
Anterior segment dysgenesis 7, Anterior segment dysgenesis 7 |
| RS1316675443 |
BMPER
|
Health Risk |
Pathogenic |
— |
| RS1316686443 |
STXBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 4 |
| RS1316690885 |
DIS3L2
|
Health Risk |
Pathogenic |
Perlman syndrome, Perlman syndrome |
| RS1316692489 |
MYH7
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS1316696594 |
FOXI3
|
Health Risk |
Likely pathogenic |
Craniofacial microsomia 1, Craniofacial microsomia 1 |
| RS1316703353 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome, KMT2D-related disorder |
| RS1316718953 |
PDE6B
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1316745675 |
RAB27A
|
Health Risk |
Pathogenic |
Griscelli syndrome type 2, Griscelli syndrome type 2 |
| RS1316749927 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS1316755014 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Facial dysmorphism-immunodeficiency-livedo-short stature syndrome, Hereditary cancer-predisposing syndrome |
| RS1316766241 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1316806485 |
F11
|
Health Risk |
Likely pathogenic |
Hereditary factor XI deficiency disease, Hereditary factor XI deficiency disease |
| RS1316844536 |
KIF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuropathy, hereditary sensory |
| RS1316885634 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1316902116 |
SMAD4
|
Health Risk |
Likely pathogenic |
Juvenile polyposis syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1316926587 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1316928806 |
PCDH19
|
Health Risk |
Likely pathogenic |
— |
| RS1316931773 |
RTEL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS1316934987 |
ABCA4
|
Health Risk |
Likely pathogenic |
— |
| RS1316946673 |
HEXA
|
Health Risk |
Likely pathogenic |
Tay-Sachs disease, Tay-Sachs disease |
| RS1316948611 |
VPS13C
|
Health Risk |
Pathogenic |
— |
| RS1316950815 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1316952160 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS1316956248 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Gorlin syndrome |
| RS1316958324 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Inborn genetic diseases |
| RS1316985932 |
POMK
|
Health Risk |
Pathogenic/Likely pathogenic |
POMK-related disorder, Limb-girdle muscular dystrophy due to POMK deficiency |
| RS1316990533 |
DYM
|
Health Risk |
Likely pathogenic |
— |
| RS1316999302 |
DNM1L
|
Health Risk |
Likely pathogenic |
Mitochondrial disease, DNM1L-related disorder |
| RS1316999782 |
HNF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young type 3, Maturity-onset diabetes of the young |
| RS1317003529 |
PCCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1317003987 |
DCLRE1C
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency due to DCLRE1C deficiency, Histiocytic medullary reticulosis |
| RS1317009723 |
MFN2
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1317010570 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS1317017233 |
PCCB
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1317036540 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital multicore myopathy with external ophthalmoplegia, Malignant hyperthermia |
| RS1317050260 |
XPC
|
Health Risk |
Pathogenic/Likely pathogenic |
Xeroderma pigmentosum, group C |
| RS1317051984 |
ALS2
|
Health Risk |
Pathogenic |
Infantile-onset ascending hereditary spastic paralysis, Infantile-onset ascending hereditary spastic paralysis |
| RS1317078806 |
CACNA2D2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, Cerebellar atrophy with seizures and variable developmental delay |
| RS1317080057 |
ACADS
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of butyryl-CoA dehydrogenase, Deficiency of butyryl-CoA dehydrogenase |
| RS1317094682 |
LOXHD1
|
Health Risk |
Likely pathogenic |
— |
| RS1317098432 |
LPIN2
|
Health Risk |
Pathogenic |
Majeed syndrome, Majeed syndrome |
| RS1317100453 |
FANCB
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group B, VACTERL association |